Virtual Reality exposure therapy for public speaking anxiety in routine care: a single-subject effectiveness trial

Cogn Behav Ther. 2021 Jan;50(1):67-87. doi: 10.1080/16506073.2020.1795240. Epub 2020 Sep 1.

Abstract

Virtual Reality (VR) can be used as a therapeutic tool to conduct efficacious in-session exposure therapy by presenting virtual equivalents of phobic stimuli, yet past hardware restrictions hindered implementation in routine care and effectiveness studies. The current study examines the effectiveness of a VR-assisted treatment protocol for public speaking anxiety with demonstrated efficacy, this time in routine care, using affordable VR hardware. Participants (n = 23) were recruited via a private clinic and treated by one of four psychologists with only minimal VR-training. Using a single-subject design and dual-slope modeling (adjusting the treatment-onset slope for treatment effects), we found a significant, large decrease in self-rated public speaking anxiety following the primary three-hour session, similar in magnitude to the previous efficacy trial. Multilevel modeling of in-session process measures suggests that the protocol works as intended, by decreasing catastrophic belief expectancy and distress, and increasing perceived performance quality. Adherence to the online transition program that followed-encouraging in-vivo exposure-was relatively poor, yet symptoms decrease continued. No change was observed over the three-month follow-up period. We conclude that VR exposure therapy can be effective under routine care conditions and is an attractive approach for future, large-scale implementation and effectiveness trials.

Keywords: Fear of public speaking; Glossophobia; Virtual Reality; effectiveness; exposure therapy.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Anxiety / therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Speech*
  • Treatment Outcome
  • Virtual Reality Exposure Therapy*